Company profile: Pfanstiehl
1.1 - Company Overview
Company description
- Provider of cGMP-produced high-purity, injectable-grade excipients and bioprocessing solutions, specializing in isolation, purification, custom synthesis, and scale-up of regulated, low endotoxin injectable formulation ingredients, pharmaceutical intermediates, and APIs in gram to multi-ton quantities. Products include TRIS HCl, sodium gluconate, sucrose, trehalose, galactose, and L-arginine.
Products and services
- Trehalose: A disaccharide that stabilizes proteins, lipids, and carbohydrates in biopharmaceutical formulations, especially during freeze-thaw cycles
- Injectable-grade
- Sucrose: A disaccharide utilized in biopharmaceutical formulations for stabilizing proteins, lipids, and carbohydrates during formulation and freeze-thaw cycles
- CGMP-produced
- TRIS HCl: A biocompatible buffering agent applied in pharmaceutical formulations to maintain stable pH levels and for protein and enzyme purification
- High purity
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Pfanstiehl
Medfiles
HQ: Finland
Website
- Description: Provider of full-service contract research organization (CRO) services for the pharma, biotech, food, and medical device industries; first private CRO in Finland and the largest by range of services, with operations across the Nordic and Baltic countries.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Medfiles company profile →
Dark Horse Consulting
HQ: United States
Website
- Description: Provider of consulting services for cell and gene therapy development, including process codification and evaluation, development planning, analytical development for potency assays, buyer-side diligence, Phase III readiness reviews, comparability study design to demonstrate manufacturing equivalence, contract manufacturing management, facility design, and device development for manufacturing equipment.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Dark Horse Consulting company profile →
ShangPharma Innovation
HQ: United States
Website
- Description: Provider of global innovation incubation and investment focused on biomedical R&D technologies and therapeutics.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full ShangPharma Innovation company profile →
Optimer Pharmaceuticals
HQ: United States
Website
- Description: Provider of anti-infective biopharmaceutical products focused on discovering, developing and commercializing treatments for gastrointestinal infections, including late-stage candidates fidaxomicin and Pruvel (prulifloxacin).
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Optimer Pharmaceuticals company profile →
Amerilab Technologies
HQ: United States
Website
- Description: Provider of effervescent product manufacturing and development, producing effervescent tablets for dietary supplements, nutraceuticals, herbals and pharmaceuticals; effervescent and non-effervescent powders in sachets or sticks; packaging and pouching (tubed and foil wrapping, sachet/stick); R&D from concept to commercialization; and custom formulation, blending, tableting and packaging services.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Amerilab Technologies company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Pfanstiehl
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Pfanstiehl
2.2 - Growth funds investing in similar companies to Pfanstiehl
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Pfanstiehl
4.2 - Public trading comparable groups for Pfanstiehl
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →